Nigeria – Healthcare, Regulatory and Reimbursement Landscape

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

GlobalData, the industry analysis specialist, has released its latest report “Nigeria – Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Nigeria. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Nigeria’s pharmaceutical market has high potential and is one of the fastest developing pharmaceutical markets in Africa. The rise in communicable and non-communicable diseases, and government initiatives such as National Drug Policy intended to drive the growth of the Nigerian pharmaceutical market. While inadequate power and water supply, dysfunctional transport system, and under-utilized manufacturing capacity, along with counterfeiting drugs are hindering the development of the healthcare market. Nigeria’s pharmaceutical market, based on pharmaceutical production value, 1.03B in 2014 is expected to increase to $3.24B in 2021 at a Compound Annual Growth Rate (CAGR) of 18%. It is forecast to reach about $5.30B in 2024. The medical devices market of Nigeria was valued at $134.7M in 2018, which is expected to increase to $174.4M in 2021 at a CAGR of 9%. The medical device market is expected to grow at a CAGR of 9% from $174.4M in 2021 to $201.8M in 2023.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Nigeria, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.

Profiles and SWOT analyses of the major players in the pharmaceutical market: Novartis, GlaxoSmithKline, Pfizer, Sanofi, and Fidson.

Profiles and SWOT analyses of the major players in the medical device market: Abbott, GE Healthcare, and Roche.

An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.

Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving Nigerian healthcare market.

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Nigerian healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

Table of Contents

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2. Executive Summary

2.1 Executive Summary

2.2 Key Highlights – Facts about the Nigerian Healthcare Market

2.3 Key Highlights: Healthcare Startups in Nigeria

2.4 Key Events: Nigerian Healthcare Timeline, 2015-2021

2.5 Key Events: Nigerian Pharmaceutical Market

2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2020-2021

2.7 Key Events: Mergers and Acquisitions

2.8 Country Profile, Nigeria, 2020

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels, Nigeria

3.5 Pharmaceutical Market – Market Segments

3.6 COVID-19 Epidemiology, Nigeria

3.7 COVID-19 Impact and Developments in the Healthcare Market, Nigeria

3.8 Pharmaceutical Market – Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Devices Market – Major Players

5. Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Nigeria, 2020-2021

6.2 Deal Analysis: Medical Device Market, Nigeria, 2020-2021

7. HealthTech Landscape

7.1 HealthTech Landscape, Nigeria

7.2 HealthTech Deals Landscape, Nigeria

7.3 Key HealthTech Deals, Nigeria

7.4 Adoption of Technology in Healthcare, Nigeria

7.5 HealthTech Landscape, Nigeria

7.6 Digital Regulations, Nigeria

7.7 HealthTech Landscape: Benefits and Risks, Nigeria

8. Market Access

8.1 Overview of Healthcare System, Nigeria

8.2 Reimbursement Process, Nigeria

8.3 Overview of Insurance Providers, Public Insurance, Nigeria

8.4 Healthcare Spending and Prescription Drug Price Trend, Nigeria

8.5 Pricing Policies, Nigeria

8.6 Regulatory Landscape, Nigeria

8.6.1 Marketing Authorization for Pharmaceutical Products, Nigeria

8.6.2 Marketing Authorization for Medical Devices, Nigeria

8.6.3 Intellectual Property Rights, Patent, Nigeria

8.6.4 Intellectual Property Rights, Trademark, Nigeria

8.6.5 Clinical Trial Regulation Process, Nigeria

8.6.6 Pharmaceutical Clinical Trials Landscape, Nigeria

8.6.7 Pharmaceutical Export and Import, Nigeria

8.6.8 Pharmaceutical Advertising Regulations, Nigeria

8.6.9 Pharmacy Regulations, Nigeria

8.6.10 Labeling and Packaging Regulations, Nigeria

9. Country Healthcare Landscape

9.1 Nigerian Healthcare Policy Highlights

9.2 Healthcare Facilities, Nigeria

9.3 Life Expectancy and Immunization Rate, Nigeria

9.4 Environmental Health, Nigeria

9.5 Healthcare Personnel, Nigeria

9.6 Disease Burden, Nigeria

9.7 Healthcare Expenditure, Nigeria

10. Trade Associations, Nigeria

11. Trade Fairs, Nigeria

12. Opportunities and Challenges

13. Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

Table

Table 1: COVID-19 Indicators (Number of Cases), Global and Nigeria, 2020-2021

Table 2: COVID-19-Related Travel Restrictions, Nigeria, 2020-2021

Table 3: COVID-19 Approved Vaccines, Nigeria, 2021

Table 4: Marketed Medical Devices for COVID-19, Nigeria, 2020-2021

Table 5: COVID-19 Medical Pipeline Products, Nigeria, 2020-2021

Table 6: COVID-19 IVD Products, Nigeria, 2020-2021

Table 7: Benefits of NIN, Nigeria, 2021

Table 8: Active and Inactive Applets, Nigeria, 2021

Table 9: Stakeholders in Digital Dashboard, Nigeria, 2021

Table 10: Pricing of Medicines, Nigeria, 2021

Table 11: Summary of Registration Processes with Timelines, Nigeria, 2021

Table 12: Essential Documents for Application of Clinical Trials, Nigeria, 2021

Table 13: Labelling Guidelines for Drug as per Packing, Nigeria, 2021

Table 14: Trade Fairs, Nigeria, 2021

Figures

Figure 1: Pharmaceutical Market, Nigeria, Revenue ($B), 2014-2021

Figure 2: Medical Device Market, Nigeria, Revenue ($M), 2018-2023

Figure 3: Healthcare Startups in Nigeria, 2021

Figure 4: Country Profile, Nigeria, 2020

Figure 5: Pharmaceutical Market, Nigeria, Revenue ($B), 2014-2020

Figure 6: Pharmaceutical Market, Nigeria, Revenue Forecast ($B), 2021-2024

Figure 7: Pharmaceutical Exports ($M), Nigeria, 2013-2020

Figure 8: Top Export Partners, Nigeria, 2020

Figure 9: Pharmaceutical Imports ($B), Nigeria, 2013-2020

Figure 10: Top Import Partners, Nigeria, 2020

Figure 11: Pharmaceutical Supply Channel, Nigeria, 2020

Figure 12: NSCIP’s Tree of Execution and Excellence, Nigeria, 2020

Figure 13: 10 Supply Chain Innovations by the Nigerian Supply Chain Integration Project (NSCIP), Nigeria, 2020

Figure 14: Adoption of Blockchain Technology in Supply Channel, Nigeria, 2020

Figure 15: COVID-19 Cases, Nigeria, 2020-2021

Figure 16: COVID-19 Deaths, Nigeria, 2020-2021

Figure 17: COVID-19 Fiscal Stimulus Timeline, Nigeria, 2020-2021

Figure 18: COVID-19 Market Development, Nigeria, 2020-2021

Figure 19: COVID-19 Vaccination Progress, Nigeria, 2021

Figure 20: COVID-19 Vaccination Plan, Nigeria, 2021

Figure 21: COVID-19 Vaccination Strategy “TEACH”, Nigeria, 2021

Figure 22: Objectives of Nigeria COVID-19 Preparedness and Response Project (NCPRP), Nigeria, 2020-2021

Figure 23: Medical Devices Market, Nigeria, Revenue ($M), 2018-2023

Figure 24: Medical Devices Market Categories, Nigeria, Revenue ($M), 2018

Figure 25: Medical Devices Market, Revenue ($B) of Major Companies, Nigeria, 2020

Figure 26: Deal Value and Deal Count, Pharmaceutical Market, Nigeria, 2017-2021

Figure 27: Deal Value and Deal Count Subtypes, Pharmaceutical Market, Nigeria, 2017-2021

Figure 28: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Nigeria, 2017-2021

Figure 29: Top Therapy Areas by Deal Value, Pharmaceutical Market, Nigeria, 2017-2021

Figure 30: Top Therapy Areas by Deal Count, Pharmaceutical Market, Nigeria, 2017-2021

Figure 31: M&A Deals by Quarter, Pharmaceutical Market, Nigeria, 2017-2021 (by Value and by Number)

Figure 32: VC Deals by Quarter, Pharmaceutical Market, Nigeria, 2017-2021 (by Value and by Number)

Figure 33: Deal Value and Deal Count, Medical Devices Market, Nigeria, 2017-2021

Figure 34: Deal Count Subtypes, Medical Devices Market, Nigeria, 2017-2021

Figure 35: Deal Value and Deal Count, Quarterly, Medical Devices Market, Nigeria, 2017-2021

Figure 36: Top Equipment Sectors by Deal Value and Deal Count, Medical Devices Market, Nigeria, 2017-2021

Figure 37: Deal Value ($M) and Deal Count, HealthTech, Nigeria, 2019-2021

Figure 38: Deal Value and Deal Count (Number of Deals) by sector, HealthTech, Nigeria, 2019-2021

Figure 39: Benefits of e-ID Card, Nigeria, 2021

Figure 40: Digital Regulations, Nigeria, 2021

Figure 41: National Health ICT Vision, Nigeria, 2021

Figure 42: Objectives of National Digital Economy Policy and Strategy (2020-2030), Nigeria, 2021

Figure 43: 8 Pillars of National Digital Economy Policy and Strategy (2020-2030), Nigeria, 2021

Figure 44: Organization of the Health System, Nigeria, 2020

Figure 45: Programs of the NHIS, Nigeria, 2021

Figure 46: Core Values of the NHIS, Nigeria, 2021

Figure 47: OOP Expenditure (% of Total Expenditure on Health), Nigeria, 2013-2020

Figure 48: Annual Rate of Change, Health Index (in %), Nigeria, 2013-2021

Figure 49: NAFDAC Organization Chart, Nigeria, 2021

Figure 50: Market Authorization Procedure, Nigeria, 2021

Figure 51: New Medical Approval Process, Nigeria, 2021

Figure 52: Patent Approval Process, Nigeria, 2021

Figure 53: Trademark Fees, Nigeria, 2021

Figure 54: Application Filing for Clinical Trials, Nigeria, 2021

Figure 55: Pharmaceutical Clinical Trials Count by Trial Status, Nigeria, 2020-2021

Figure 56: Pharmaceutical Clinical Trials Count by Indication, Nigeria, 2020-2021

Figure 57: Pharmaceutical Clinical Trials Count by Phase, Nigeria, 2020-2021

Figure 58: Top Two Pharmaceutical Clinical Trial Sponsors by Count, Nigeria, 2020-2021

Figure 59: Steps for Registration of Imported Drug Products, Nigeria, 2021

Figure 60: Labeling Regulations for Drug Products, Nigeria, 2021

Figure 61: Public-Private Hospitals, Nigeria, 2019

Figure 62: Share of Public and Private CT Scanner Units (in %), Nigeria, 2018

Figure 63: Life Expectancy at Birth (Years), Nigeria, 2012-2019

Figure 64: Immunization Rate (%), Nigeria, 2013-2019

Figure 65: PM2.5 (µg per m3), Nigeria, 2013-2019

Figure 66: CO2 Emissions (Million Tons), Nigeria, 2012-2018

Figure 67: Physicians (per 1,000 population), Nigeria, 2013-2020

Figure 68: Nurses (per 1,000 population), Nigeria, 2013-2020

Figure 69: Dentists (per 1,000 population), Nigeria, 2013-2020

Figure 70: Major Causes of Mortality (per 100,000 population), Nigeria, 2019

Figure 71: Major Causes of Male Mortality (per 100,000 population), Nigeria, 2019

Figure 72: Major Causes of Female Mortality (per 100,000 population), Nigeria, 2019

Figure 73: DALYs by Major Disease (per 100,000 population), Nigeria, 2019

Figure 74: Healthcare Expenditure as Percentage of GDP (%), Nigeria, 2014-2020

Figure 75: Health Expenditure Share (% of Total Health Spending), Nigeria, 2013-2020

Figure 76: Opportunities and Challenges

Frequently asked questions

Nigeria – Healthcare, Regulatory and Reimbursement Landscape thematic reports
Currency USD
$1,995

Can be used by individual purchaser only

$5,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Nigeria – Healthcare, Regulatory and Reimbursement Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Nigeria – Healthcare, Regulatory and Reimbursement Landscape in real time.

  • Access a live Nigeria – Healthcare, Regulatory and Reimbursement Landscape dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.